Our Sites » TechNews TechDatabase Canadian Private Equity Register     Login

Home » US Foreign » Cerecor Completes $22 Million Series A

Cerecor Completes $22 Million Series A

Cerecor Inc., a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in the human nervous system, has secured an addition closing to bring its Series A round to US $22 million, significantly above its proposed maximum offering of $15 million.

The offering, which was placed with accredited investors including members of Cerecor’s board of directors.

Maxim Group, LLC of New York, NY acted as placement agent in connection with the offering.

Copyright © 2013 TechFinance.ca. All rights reserved. | Healthy Living | wp-tips.
More in US Foreign (17 of 102 articles)